Additionally, monoclonal IgMs from healthy donors reduced the self-reactivity of B lymphocytes, enhanced the generation of regulatory T cells (Tregs), and reversed T1D in NOD mice, indicating that naturally produced Igs may also emerge as a viable treatment option for T1D (39). The gene discussed is CUBN; the disease is type 1 diabetes mellitus.